Turing Lengthy Letter Harangues Express Scripts/Imprimis Deal
This article was originally published in Scrip
Executive Summary
Turing Pharmaceuticals AG – the company that infamously raised the price of its toxoplasmosis drug Daraprim (pyrimethamine) by more than 5,000% – told three infectious disease groups they were wrong for throwing their support last week behind Express Scripts Holding Co.'s move to add Imprimis Pharmaceuticals Inc.'s compounded formulation of pyrimethamine with leucovorin on the pharmacy benefit management (PBM) company's formulary.